N/A Completed N=31,439 Randomized Single-blind Screening

SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Text Message Study

COVID

Source: ClinicalTrials.gov NCT05533918 ↗

Enrolled (actual)

31,439

Serious AEs

0.0%

Results posted

Jan 2025

Primary outcomePrimary: Reach-Accept Testing — 509; 423; 351; 329 Participants

Summary

The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team has established population health management (PHM) interventions that have been used since Feb 2021 to increase the uptake of COVID-19 testing and vaccination among community health center patients. Interventions are based on a PHM approach that uses widely available technology (i.e. cell phones and text messaging). SCALE-UP II will both build on SCALE-UP Utah PHM interventions and investigate novel resource conservation approaches (i.e., Request-Patient Navigation vs. No Patient Navigation and text messaging vs. conversational agent). SCALE-UP II builds on long standing partnerships among the University of Utah Clinical and Translational Science Institute (UofU CTSI), Association for Utah Community Health (AUCH), CHCs, and the Utah Department of Health(UDOH). CTSI and SCALE-UP II investigators are leading several COVID-19 initiatives that drive public health response and state government policies in Utah.

Outcome Measures

Outcome	Result	p-value
PRIMARY Reach-Accept Testing	509; 423; 351; 329	—
SECONDARY Reach-Engage Testing	785; 637; 603; 554	—
SECONDARY PN-Request	0; 0; 11; 8	—
SECONDARY PN-Engage	0; 0; 9; 6	—
SECONDARY Opt-out	982; 583; 995; 564	—
SECONDARY Self Reported Testing	94; 86; 63; 72	—

Eligibility Criteria

Inclusion Criteria

current patient of a participating community health center
have a working cellphone,
have phone number listed in existing electronic medical record at their participating clinic
speak English or Spanish.

Exclusion Criteria

Minors

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05533918). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.